1. Home
  2. WYY vs MDAI Comparison

WYY vs MDAI Comparison

Compare WYY & MDAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo WidePoint Corporation

WYY

WidePoint Corporation

HOLD

Current Price

$7.97

Market Cap

48.1M

Sector

Technology

ML Signal

HOLD

MDAI

Spectral AI Inc.

HOLD

Current Price

$2.24

Market Cap

39.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WYY
MDAI
Founded
1991
2013
Country
United States
United States
Employees
N/A
78
Industry
EDP Services
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
48.1M
39.6M
IPO Year
2005
N/A

Fundamental Metrics

Financial Performance
Metric
WYY
MDAI
Price
$7.97
$2.24
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
1
Target Price
$8.67
$3.00
AVG Volume (30 Days)
81.2K
382.8K
Earning Date
05-14-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$150,545,364.00
N/A
Revenue This Year
$14.41
N/A
Revenue Next Year
$11.41
$23.50
P/E Ratio
N/A
N/A
Revenue Growth
5.59
N/A
52 Week Low
$2.80
$1.13
52 Week High
$10.49
$3.21

Technical Indicators

Market Signals
Indicator
WYY
MDAI
Relative Strength Index (RSI) 68.07 73.04
Support Level $4.59 $2.02
Resistance Level N/A $2.80
Average True Range (ATR) 0.80 0.12
MACD 0.41 0.03
Stochastic Oscillator 61.25 85.30

Price Performance

Historical Comparison
WYY
MDAI

About WYY WidePoint Corporation

WidePoint Corp is a provider of Technology Management as a Service (TMaaS) that consists of federally certified communications management, identity management, interactive bill presentment and analytics, and an Information Technology as a Service solution. Its solutions include Telecom Lifecycle Management, Digital billing communications solutions, and Mobile and Identity management. Geographically, the company generates a majority of its revenue from the United States and the rest from Europe.

About MDAI Spectral AI Inc.

Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.

Share on Social Networks: